MEGI vs VOR
Comparison between MainStay CBRE Global Infrastructure Megatrends Fund (MEGI, Company) and Vor Biopharma Inc (VOR, Company).
MEGI is from the Financial Services sector, while VOR is from the Healthcare sector.
5-Year PerformanceMEGI has outperformed VOR, delivering a return of +3.7% compared to -48.9%
MEGI vs VOR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
MEGI vs VOR - Historical Returns
Returns include dividend reinvestment.
MEGI vs VOR - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | MEGI | VOR |
|---|---|---|
| 2026 | +12.81% | +24.48% |
| 2025 | +21.62% | -41.61% |
| 2024 | +4.51% | -50.22% |
| 2023 | +4.43% | -66.72% |
| 2022 | -24.03% | -45.63% |
| 2021 | -3.50% | -69.01% |
MEGI vs VOR Drawdown Comparison
The maximum drawdown for MEGI was -39.45%, occurring on Oct 12, 2022. Recovery took 866 trading sessions.
The maximum drawdown for VOR was -99.72%, occurring on May 9, 2025. This drawdown has not yet recovered.
The current MEGI drawdown is -2.20%. The current VOR drawdown is -98.66%.
| Rank | MEGI | VOR |
|---|---|---|
| #1 | -39.45% Jan 14, 2022 - Jul 1, 2025 | -99.72% Feb 25, 2021 - May 9, 2025 |
| #2 | -13.72% Nov 23, 2021 - Jan 14, 2022 | -16.81% Feb 16, 2021 - Feb 24, 2021 |
| #3 | -9.52% Feb 27, 2026 - Mar 26, 2026 | -1.99% Feb 10, 2021 - Feb 12, 2021 |
| #4 | -8.43% Oct 6, 2025 - Feb 6, 2026 | N/A |
| #5 | -3.05% Jul 16, 2025 - Jul 23, 2025 | N/A |
| #6 | -2.70% Jul 1, 2025 - Jul 16, 2025 | N/A |
| #7 | -2.05% Sep 15, 2025 - Sep 30, 2025 | N/A |
| #8 | -1.92% Aug 28, 2025 - Sep 15, 2025 | N/A |
| #9 | -1.66% Aug 4, 2025 - Aug 25, 2025 | N/A |
| #10 | -1.23% Feb 13, 2026 - Feb 20, 2026 | N/A |
| #11 | -1.14% Jul 23, 2025 - Aug 4, 2025 | N/A |
| #12 | -0.25% Nov 1, 2021 - Nov 17, 2021 | N/A |
| #13 | -0.13% Oct 1, 2025 - Oct 3, 2025 | N/A |
Correlation
Correlation between MEGI and VOR is -0.13 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks